{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:59:51Z","timestamp":1793753991912,"version":"4.6.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.cmi.2026.05.029","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:00:30Z","timestamp":1780038030000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of doxycycline post-exposure prophylaxis on Neisseria gonorrhoeae antimicrobial resistance to doxycycline and ceftriaxone in Milan, Italy"],"prefix":"10.1016","author":[{"given":"Angelo Roberto","family":"Raccagni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Sagramoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2","family":"Capra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Lolatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Maria","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Carletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Loi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bruzzesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Nozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2026.05.029_bib1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1473-3099(17)30725-9","article-title":"Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial","volume":"18","author":"Molina","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2026.05.029_bib2","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa2211934","article-title":"Postexposure doxycycline to prevent bacterial sexually transmitted infections","volume":"388","author":"Luetkemeyer","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2026.05.029_bib3","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1473-3099(24)00236-6","article-title":"Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 \u00d7 2 factorial design","volume":"24","author":"Molina","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2026.05.029_bib4","doi-asserted-by":"crossref","unstructured":"Bercot B, Assoumou L, Cam\u00e9l\u00e9na F, Voitichouk C, M\u00e9rim\u00e8che M, Ouattara M, et al. Antimicrobial drug-resistant Neisseria gonorrhoeae (GC) infections in men using doxycycline postexposure prophylaxis: a substudy of the ANRS 174 DOXYVAC trial. Clin Infect Dis. In press. DOI:https:\/\/doi.org\/10.1093\/cid\/ciaf591.","DOI":"10.1093\/cid\/ciaf591"},{"key":"10.1016\/j.cmi.2026.05.029_bib5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/OLQ.0000000000001810","article-title":"Doxycycline postexposure prophylaxis could induce cross-resistance to other classes of antimicrobials in Neisseria gonorrhoeae: an in silico analysis","volume":"50","author":"Vanbaelen","year":"2023","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.cmi.2026.05.029_bib6","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1016\/S1473-3099(23)00359-6","article-title":"Selection of Neisseria gonorrhoeae ceftriaxone resistance using doxycycline post-exposure prophylaxis","volume":"23","author":"Whiley","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2026.05.029_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(25)00234-8","article-title":"Doxy-PEP could select for ceftriaxone resistance in Neisseria gonorrhoeae","volume":"25","author":"Vanbaelen","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2026.05.029_bib8","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamainternmed.2025.0984","article-title":"Doxycycline postexposure prophylaxis could accelerate the emergence of gonococcal ceftriaxone resistance","volume":"185","author":"Kenyon","year":"2025","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cmi.2026.05.029_bib9","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2026.31.2.2500965","article-title":"High prevalence of tetracycline resistance in Neisseria gonorrhoeae across 22 European countries, 2024","volume":"31","author":"Jacobsson","year":"2026","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2026.05.029_bib10","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae and its risk groups in 23 European countries in 2022 within the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP): a retrospective observational study","volume":"54","author":"Jacobsson","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.cmi.2026.05.029_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/sextrans-2025-056595","article-title":"Attitudes and prescribing practices on doxycycline postexposure prophylaxis (DoxyPEP) among Italian infectious diseases physicians: findings from a National SIMIT Survey","volume":"102","author":"Rossotti","year":"2026","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.cmi.2026.05.029_bib12","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2026.05.029_bib13","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1016\/S2666-5247(22)00044-1","article-title":"Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study","volume":"3","author":"S\u00e1nchez-Bus\u00f3","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.cmi.2026.05.029_bib14","doi-asserted-by":"crossref","unstructured":"Elsener TA, Dillon JAR, Shafer WM, Tang CM. Plasmids in Neisseria gonorrhoeae: drivers of DoxyPEP failure and an emerging threat for current therapy. Clin Microbiol Rev. In press. DOI:https:\/\/doi.org\/10.1128\/cmr.00252-25.","DOI":"10.1128\/cmr.00252-25"},{"key":"10.1016\/j.cmi.2026.05.029_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlaf120","article-title":"Tetracycline-resistant Neisseria gonorrhoeae global estimates-impacts on doxycycline post-exposure prophylaxis implementation and monitoring: a systematic review","volume":"7","author":"Do","year":"2025","journal-title":"JAC Antimicrob Resist"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26002715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26002715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T03:34:03Z","timestamp":1781494443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X26002715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":15,"alternative-id":["S1198743X26002715"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2026.05.029","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of doxycycline post-exposure prophylaxis on Neisseria gonorrhoeae antimicrobial resistance to doxycycline and ceftriaxone in Milan, Italy","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2026.05.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}